Bioanalytical Testing Services Market by Type (Biomarker Testing, Cell-Based Assays, Method Development Optimization & Validation), Application (Cardiology, Gastroenterology, Infectious Diseases), End User - Global Forecast 2023-2030
The Bioanalytical Testing Services Market is projected to reach USD 8.24 billion by 2030 from USD 3.95 billion in 2022, at a CAGR of 9.61% during the forecast period.
Market Segmentation & Coverage:
This research report analyzes various sub-markets, forecasts revenues, and examines emerging trends in each category to provide a comprehensive outlook on the Bioanalytical Testing Services Market.
- Based on Type, market is studied across Biomarker Testing, Cell-Based Assays, Method Development Optimization & Validation, Pharmacokinetic Testing, Serology, Immunogenicity, & Neutralizing Antibodies, and Virology Testing. The Cell-Based Assays is further studied across Bacterial Cell-Based Assays and Viral Cell-Based Assays. The Virology Testing is further studied across In Vitro Virology Testing, In Vivo Virology Testing, and Species-Specific Viral PCR Assays. The Biomarker Testing is projected to witness significant market share during forecast period.
- Based on Application, market is studied across Cardiology, Gastroenterology, Infectious Diseases, Neurology, and Oncology. The Cardiology is projected to witness significant market share during forecast period.
- Based on End User, market is studied across Contract Development & Manufacturing Organizations, Contract Research Organizations, and Pharmaceutical & Biopharmaceutical Companies. The Contract Development & Manufacturing Organizations is projected to witness significant market share during forecast period.
- Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.
The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix is an indispensable tool for assessing the Bioanalytical Testing Services Market. It comprehensively evaluates vendors, analyzing key metrics related to Business Strategy and Product Satisfaction. This enables users to make informed decisions tailored to their specific needs. Through advanced analysis, vendors are categorized into four distinct quadrants, each representing a different level of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V). Be assured that this insightful framework empowers decision-makers to navigate the market with confidence.
Market Share Analysis:
The Market Share Analysis offers invaluable insights into the vendor landscape Bioanalytical Testing Services Market. By evaluating their impact on overall revenue, customer base, and other key metrics, we provide companies with a comprehensive understanding of their performance and the competitive environment they confront. This analysis also uncovers the level of competition in terms of market share acquisition, fragmentation, dominance, and industry consolidation during the study period.
Key Company Profiles:
The report delves into recent significant developments in the Bioanalytical Testing Services Market, highlighting leading vendors and their innovative profiles. These include Absorption Systems LLC, Almac Group Limited, Altasciences, BioAgilytix Labs, LLC, Celerion, Inc., Charles River Laboratories International, Inc., Eurofins Scientific SE, Frontage Laboratories, Inc., Icon PLC, Intertek Group PLC, IQVIA Holdings Inc., Laboratory Corporation of America Holdings, LGC Limited, Lotus Labs Pvt. Ltd., Lotus Labs Pvt. Ltd. by Teva Pharmaceutical Industries Ltd., Medpace Holdings, Inc., NorthEast BioAnalytical Laboratories LLC, Pace Analytical Services LLC, Parexel International Corporation, PPD Inc., Q2 Solutions, SGS Société Générale de Surveillance SA, Syneos Health, LLC, and WuXi AppTec Co., Ltd..
The report offers valuable insights on the following aspects:
- Market Penetration: It provides comprehensive information about key players' market dynamics and offerings.
- Market Development: In-depth analysis of emerging markets and penetration across mature market segments, highlighting lucrative opportunities.
- Market Diversification: Detailed information about new product launches, untapped geographies, recent developments, and investments.
- Competitive Assessment & Intelligence: Exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of leading players.
- Product Development & Innovation: Intelligent insights on future technologies, R&D activities, and breakthrough product developments.
- What is the market size and forecast for the Bioanalytical Testing Services Market?
- Which products, segments, applications, and areas hold the highest investment potential in the Bioanalytical Testing Services Market?
- What is the competitive strategic window for identifying opportunities in the Bioanalytical Testing Services Market?
- What are the latest technology trends and regulatory frameworks in the Bioanalytical Testing Services Market?
- What is the market share of the leading vendors in the Bioanalytical Testing Services Market?
- Which modes and strategic moves are suitable for entering the Bioanalytical Testing Services Market?
Note: PDF & Excel + Online Access - 1 Year
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Limitations
- 1.7. Assumptions
- 1.8. Stakeholders
- 2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
- 3. Executive Summary
- 4. Market Overview
- 4.1. Introduction
- 4.2. Bioanalytical Testing Services Market, by Region
- 5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Rising focus on the analytical testing of biologics and biosimilars
- 5.1.1.2. Growing R&D expenditure in the pharmaceutical and biopharmaceutical industry
- 5.1.1.3. Rising adoption of the quality by design approach
- 5.1.2. Restraints
- 5.1.2.1. Pricing pressure and dearth of skilled professionals faced by major players
- 5.1.3. Opportunities
- 5.1.3.1. Rising demand for specialized bioanalytical testing services
- 5.1.3.2. Increasing economic efficiency offered for outsourcing rather than conducting an in-house study
- 5.1.3.3. Emergence of technological advancements and approvals of clinical trials in the bioanalytical testing services
- 5.1.4. Challenges
- 5.1.4.1. Concerns regarding innovative formulations demanding a unique bioanalytical testing approach
- 5.2. Market Segmentation Analysis
- 5.3. Market Trend Analysis
- 5.4. Cumulative Impact of COVID-19
- 5.5. Cumulative Impact of Russia-Ukraine Conflict
- 5.6. Cumulative Impact of High Inflation
- 5.7. Porter’s Five Forces Analysis
- 5.7.1. Threat of New Entrants
- 5.7.2. Threat of Substitutes
- 5.7.3. Bargaining Power of Customers
- 5.7.4. Bargaining Power of Suppliers
- 5.7.5. Industry Rivalry
- 5.8. Value Chain & Critical Path Analysis
- 5.9. Regulatory Framework
- 5.10. Client Customization
- 6. Bioanalytical Testing Services Market, by Type
- 6.1. Introduction
- 6.2. Biomarker Testing
- 6.3. Cell-Based Assays
- 6.4.1. Bacterial Cell-Based Assays
- 6.4.2. Viral Cell-Based Assays
- 6.4. Method Development Optimization & Validation
- 6.5. Pharmacokinetic Testing
- 6.6. Serology, Immunogenicity, & Neutralizing Antibodies
- 6.7. Virology Testing
- 6.8.1. In Vitro Virology Testing
- 6.8.2. In Vivo Virology Testing
- 6.8.3. Species-Specific Viral PCR Assays
- 7. Bioanalytical Testing Services Market, by Application
- 7.1. Introduction
- 7.2. Cardiology
- 7.3. Gastroenterology
- 7.4. Infectious Diseases
- 7.5. Neurology
- 7.6. Oncology
- 8. Bioanalytical Testing Services Market, by End User
- 8.1. Introduction
- 8.2. Contract Development & Manufacturing Organizations
- 8.3. Contract Research Organizations
- 8.4. Pharmaceutical & Biopharmaceutical Companies
- 9. Americas Bioanalytical Testing Services Market
- 9.1. Introduction
- 9.2. Argentina
- 9.3. Brazil
- 9.4. Canada
- 9.5. Mexico
- 9.6. United States
- 10. Asia-Pacific Bioanalytical Testing Services Market
- 10.1. Introduction
- 10.2. Australia
- 10.3. China
- 10.4. India
- 10.5. Indonesia
- 10.6. Japan
- 10.7. Malaysia
- 10.8. Philippines
- 10.9. Singapore
- 10.10. South Korea
- 10.11. Taiwan
- 10.12. Thailand
- 10.13. Vietnam
- 11. Europe, Middle East & Africa Bioanalytical Testing Services Market
- 11.1. Introduction
- 11.2. Denmark
- 11.3. Egypt
- 11.4. Finland
- 11.5. France
- 11.6. Germany
- 11.7. Israel
- 11.8. Italy
- 11.9. Netherlands
- 11.10. Nigeria
- 11.11. Norway
- 11.12. Poland
- 11.13. Qatar
- 11.14. Russia
- 11.15. Saudi Arabia
- 11.16. South Africa
- 11.17. Spain
- 11.18. Sweden
- 11.19. Switzerland
- 11.20. Turkey
- 11.21. United Arab Emirates
- 11.22. United Kingdom
- 12. Competitive Landscape
- 12.1. FPNV Positioning Matrix
- 12.2. Market Share Analysis, By Key Player
- 12.3. Competitive Scenario Analysis, By Key Player
- 13. Competitive Portfolio
- 13.1. Key Company Profiles
- 13.1.1. Absorption Systems LLC
- 13.1.2. Almac Group Limited
- 13.1.3. Altasciences
- 13.1.4. BioAgilytix Labs, LLC
- 13.1.5. Celerion, Inc.
- 13.1.6. Charles River Laboratories International, Inc.
- 13.1.7. Eurofins Scientific SE
- 13.1.8. Frontage Laboratories, Inc.
- 13.1.9. Icon PLC
- 13.1.10. Intertek Group PLC
- 13.1.11. IQVIA Holdings Inc.
- 13.1.12. Laboratory Corporation of America Holdings
- 13.1.13. LGC Limited
- 13.1.14. Lotus Labs Pvt. Ltd.
- 13.1.15. Lotus Labs Pvt. Ltd. by Teva Pharmaceutical Industries Ltd.
- 13.1.16. Medpace Holdings, Inc.
- 13.1.17. NorthEast BioAnalytical Laboratories LLC
- 13.1.18. Pace Analytical Services LLC
- 13.1.19. Parexel International Corporation
- 13.1.20. PPD Inc.
- 13.1.21. Q2 Solutions
- 13.1.22. SGS Société Générale de Surveillance SA
- 13.1.23. Syneos Health, LLC
- 13.1.24. WuXi AppTec Co., Ltd.
- 13.2. Key Product Portfolio
- 14. Appendix
- 14.1. Discussion Guide
- 14.2. License & Pricing
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook